Blog

Home » Blog

VIDEO: Dr. Saibish “The current role of Brachytherapy”

      May 2013 Scotiabank Awateness Night Dr. Saibishkumar Elantholi Parameswaran, “Dr. Saibish” MBBS, MD, FRCPC Assistant Professor,  Department of Radiation Oncology, University of TorontoRadiation Oncologist, The Princess Margaret University Health Network “Prostate cancer treatment: the current role of Brachytherapy” In early-stage prostate cancer, brachytherapy has a proven performance that is on a par with benchmark prostate cancer treatments such as the radical prostatectomy.The indications for use of this approach are expanding, and modifications in brachytherapy techniques have resulted in improvement in tumour-related outcomes along with better quality of life and convenience for patients with prostate cancer.This presentation details the evolution […]

VIDEO: Dr. Saibish “The current role of Brachytherapy” Read More »

Prostate Cancer Patients May Prolong Lives With Healthy Fats

Men with early stage prostate cancer may live longer if they eat a diet rich in heart-healthy nuts, vegetable oils, seeds and avocados, researchers said. Their analysis of 4,577 men found those who reported eating vegetable fats were less likely to develop fatal tumours or die from other causes than those with diets high in animal fats and carbohydrates. The study, published in JAMA Internal Medicine, is the first to analyze fat consumption after diagnosis and the risk of death. Read the article.

Prostate Cancer Patients May Prolong Lives With Healthy Fats Read More »

Brachytherapy a Good Option for Younger Prostate Cancer Patients

Brachytherapy (BT) provides excellent long-term outcomes for relatively young men with clinically localized prostate cancer (PCa), researchers reported. In a study of 236 men aged 60 years or younger with clinically localized PCa, BT alone or in combination with external beam radiation therapy (EBRT) was associated with eight-year PSA relapse-free survival (RFS), cancer-specific survival, and overall survival rates of 96%, 99%, and 96%, respectively, according to findings published in BJU International (2013;111:1231-1236). BT-based approaches also were associated with a low risk of long-term genitourinary (GI) and gastrointestinal (GI) morbidities, with erectile function preserved in more than half of patients. Read

Brachytherapy a Good Option for Younger Prostate Cancer Patients Read More »

PCCN April IBulletin

The April Info Bulletin, with a number of interesting and informative stories is available here. Below are some of the stories featured in the Info Bulletin: • Wake Up Call Breakfast • Alex Young • Springhill Penitentiary Outreach • PCCN Online • Rocco Visits PCCN Calgary • PCCN Toronto & Rocco Rossi • Prostate Cancer Expert Dr.Rob Bristow guest blogs on PCC website • PCC e-update • Web & Twitter Chats with Prostate Cancer Experts • ASAP ( A Survivorship Action Partnership) • Empire Theatres Partnership • Cruise for the Cure – by Jim Dorsey • Community Events

PCCN April IBulletin Read More »

Prostate Cancer AS May Be OK Despite Higher PSA

Active surveillance (AS) may be an appropriate management option in carefully selected prostate cancer (PCa) patients with a baseline PSA level of 10 ng/mL or higher, according to study findings presented at the American Urological Association annual meeting. The study showed that these patients are no more likely to experience pathologic progression that patients with lower PSA levels at baseline. Read the article.

Prostate Cancer AS May Be OK Despite Higher PSA Read More »

Carrots are latest weapon in the war against prostate cancer

Carrots are latest weapon in the war against prostate cancer, according to groundbreaking new research published by scientists in York. Professor Norman Maitland and his team at the University of York say a diet rich in vitamin A could be the key to beating prostate cancer because it makes the disease far more treatable. Read the article.

Carrots are latest weapon in the war against prostate cancer Read More »

VIDEO: Dr Keith Jarvi “Prostate Cancer Survivors: What Now?”

      March  2013 Scotiabank Awateness Night Dr. Keith Jarvi MD, FRCSC(C) Professor of Surgery, Division of Urology Department of Surgery University of Toronto, Chief of Urology, and Director Murray Koffler Urologic Wellness Centre Mount Sinai Hospital   “Prostate Cancer Survivors: What Now?” Survivorship issues in men with prostate cancer Incontinence, Erectile Dysfunction, Fertility, Need for radiation/chemo after surgery/radiation, In Vitro Fertilization and more.   CLICK ON THE ARROW TO START THE VIDEO Click here for Video Part 1 Click here for Video Part 2   Introduction by Allan Lappin     High Definition Part 1   17:48 minutes   

VIDEO: Dr Keith Jarvi “Prostate Cancer Survivors: What Now?” Read More »

Scroll to Top